Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City
SOUTH SAN FRANCISCO, Calif., /PRNewswire/ -- Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL) today announced that Dean Schorno, the company's executive vice president and chief financial officer, is scheduled to present a company overview at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018 at 2:20pm EST.
To access the live webcast of the presentation or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.
About Rigel (www.rigel.com)
1 The product for this use or indication is investigational and has not been proven safe or effective by any regulatory authority.
Please see www.TAVALISSE.com for full Prescribing Information.
View original content to download multimedia:http://www.prnewswire.com/news-releases/rigel-to-present-at-the-bmo-capital-markets-2018-prescriptions-for-success-healthcare-conference-in-new-york-city-300760320.html
SOURCE Rigel Pharmaceuticals, Inc.
Company Codes: NASDAQ-NMS:RIGL